VIRDY yields 1.32% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, VIRDY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VIRDY + PFE for your $10,000?
Viridien Société anonyme provides data, products, services, and solutions in Earth science, data science, sensing, and monitoring in North America, Latin America, the Central and South Americas, Europe, Africa, the Middle East, and the Asia Pacific. It operates through two segments, Data, Digital & Energy Transition (DDE); and Sensing & Monitoring (SMO). The DDE segment engages in the geoscience business, which includes the processing and imaging of geophysical data, reservoir characterization, geophysical consulting and software services, geological data library, and data management solutions, as well as collecting, developing, and licensing geological data; earth data business, which comprises the development and management of a seismic and geological data library; development and sale of seismic data processing software under the Geovation brand; and provision of geoscience and petroleum engineering consulting services. Its SMO segment engages in the design, engineering, and manufacturing of seismic equipment for the land and marine seismic data acquisition, including seismic recording equipment, software, and seismic sources; and business equipment activities, such as land, marine, ocean bottom, borehole and beyond the core infrastructure monitoring solution and defense under the Sercel, Metrolog, GRC, DeRegt, and Geocomp brands. This segment also provides customer support services, such as training. The company was formerly known as CGG and changed its name to Viridien Société anonyme in May 2024. Viridien Société anonyme was incorporated in 1931 and is headquartered in Massy, France.
Full VIRDY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.